EXICURE, INC. Payments for Restructuring
EXICURE, INC. (XCUR) reported Payments for Restructuring of $48.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-06-06.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsForRestructuring · last filed 2024-06-06
- EXICURE, INC. payments for restructuring for the quarter ending 2022-12-31 was $633.00K.
- EXICURE, INC. payments for restructuring for the quarter ending 2022-09-30 was $178.00K.
- EXICURE, INC. payments for restructuring for the quarter ending 2022-06-30 was $250.00K.
- EXICURE, INC. payments for restructuring for the quarter ending 2022-03-31 was $582.00K.
- EXICURE, INC. payments for restructuring for fiscal 2023 was $48.00K, a 97.08% decline from fiscal 2022.
- EXICURE, INC. payments for restructuring for fiscal 2022 was $1.64M.
| Period end | Payments for Restructuring 3 month | Payments for Restructuring 6 month | Payments for Restructuring 9 month | Payments for Restructuring 12 month |
|---|---|---|---|---|
| 2023-12-31 | $48.00K 10-K · filed 2024-06-06 | |||
| 2022-12-31 | $633.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-06-06 | $811.00K derived: sum of 2 quarters · filed 2024-06-06 | $1.06M derived: sum of 3 quarters · filed 2024-06-06 | $1.64M 10-K · filed 2024-06-06 |
| 2022-09-30 | $178.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $428.00K derived: sum of 2 quarters · filed 2022-11-14 | $1.01M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $250.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $832.00K 10-Q · filed 2022-08-15 | ||
| 2022-03-31 | $582.00K 10-Q · filed 2022-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |